{"id":727413,"date":"2023-01-31T16:37:20","date_gmt":"2023-01-31T21:37:20","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/"},"modified":"2023-01-31T16:37:20","modified_gmt":"2023-01-31T21:37:20","slug":"update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/","title":{"rendered":"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference"},"content":{"rendered":"
\n

NEWARK, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) — In a release issued earlier today by Rain Oncology (NASDAQ: RAIN), the company is updating their presentation date and time to Thursday, February 9, 2023, at 3:55 p.m. ET.<\/p>\n

Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the p53-MDM2 complex that reactivates p53, today announced that Avanish Vellanki, Chief Executive Officer of Rain, will be participating in a fireside chat at the Guggenheim Healthcare Talks Oncology Day Conference on Thursday, February 9, 2023, at 3:55 p.m. ET, being held in New York, NY.<\/p>\n

A live webcast of the fireside chat can be accessed here<\/a>. A replay of the event will be available on the \u201cEvents<\/a>\u201d section of the Rain website after the conclusion of the event and will be archived on the Rain website at www.rainoncology.com<\/a>.<\/p>\n

\n About Rain Oncology Inc.<\/strong>
\n
Rain Oncology Inc. is a late-stage precision oncology company developing therapies that target oncogenic drivers to genetically select patients it believes will most likely benefit. This approach includes using a tumor-agnostic strategy to select patients based on their tumors\u2019 underlying genetics rather than histology. Rain\u2019s lead product candidate, milademetan, is a small molecule, oral inhibitor of the p53-MDM2 complex that reactivates p53. In addition to milademetan, Rain is also developing a preclinical program that is focused on inducing synthetic lethality in cancer cells by inhibiting RAD52.<\/p>\n

\n Media Contact <\/strong>
\n
Jordyn Temperato
LifeSci Communications
jtemperato@lifescicomms.com<\/a><\/p>\n

\n Investor Contact<\/strong>
\n
Dan Ferry
LifeSci Advisors
+1.617.430.7576
daniel@lifesciadvisors.com<\/a>\u00a0\u00a0<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

NEWARK, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) — In a release issued earlier today by Rain Oncology (NASDAQ: RAIN), the company is updating their presentation date and time to Thursday, February 9, 2023, at 3:55 p.m. ET. Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the p53-MDM2 complex that reactivates p53, today announced that Avanish Vellanki, Chief Executive Officer of Rain, will be participating in a fireside chat at the Guggenheim Healthcare Talks Oncology Day Conference on Thursday, February 9, 2023, at 3:55 p.m. ET, being held in New York, NY. A live webcast of the fireside chat can be accessed here. A … <\/p>\n

Continue reading “UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-727413","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nUPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEWARK, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) — In a release issued earlier today by Rain Oncology (NASDAQ: RAIN), the company is updating their presentation date and time to Thursday, February 9, 2023, at 3:55 p.m. ET. Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the p53-MDM2 complex that reactivates p53, today announced that Avanish Vellanki, Chief Executive Officer of Rain, will be participating in a fireside chat at the Guggenheim Healthcare Talks Oncology Day Conference on Thursday, February 9, 2023, at 3:55 p.m. ET, being held in New York, NY. A live webcast of the fireside chat can be accessed here. A … Continue reading "UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T21:37:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference\",\"datePublished\":\"2023-01-31T21:37:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/\"},\"wordCount\":270,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/\",\"name\":\"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ==\",\"datePublished\":\"2023-01-31T21:37:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/","og_locale":"en_US","og_type":"article","og_title":"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference - Market Newsdesk","og_description":"NEWARK, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) — In a release issued earlier today by Rain Oncology (NASDAQ: RAIN), the company is updating their presentation date and time to Thursday, February 9, 2023, at 3:55 p.m. ET. Rain Oncology Inc. (NasdaqGS: RAIN), (\u201cRain\u201d), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the p53-MDM2 complex that reactivates p53, today announced that Avanish Vellanki, Chief Executive Officer of Rain, will be participating in a fireside chat at the Guggenheim Healthcare Talks Oncology Day Conference on Thursday, February 9, 2023, at 3:55 p.m. ET, being held in New York, NY. A live webcast of the fireside chat can be accessed here. A … Continue reading \"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-31T21:37:20+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference","datePublished":"2023-01-31T21:37:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/"},"wordCount":270,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/","name":"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ==","datePublished":"2023-01-31T21:37:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODc0MDIxMiM1Mzg0NjMyIzUwMDA0ODY0MQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/update-rain-oncology-to-participate-in-the-2023-guggenheim-healthcare-talks-oncology-day-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"UPDATE \u2013 Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727413","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=727413"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727413\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=727413"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=727413"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=727413"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}